{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:55:17Z","timestamp":1781744117213,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302604"],"award-info":[{"award-number":["82302604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2022ZYD0060"],"award-info":[{"award-number":["2022ZYD0060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic disorders are highly prevalent in patients with native and transplanted chronic kidney disease (CKD). However, little is known about the metabolic similarities and differences associated with declining kidney function between non-transplant patients and kidney transplant recipients (KTRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study employed gas chromatography-mass spectrometry to compare serum metabolomic profiles among native CKD subgroups and KTR subgroups, aiming to identify differential metabolites associated with kidney dysfunction in both clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>11 and 13 metabolites were associated with kidney dysfunction in native CKD patients and KTRs, respectively. Among these, L-tryptophan, D-lyxose, xylitol, erythritol, 3,4-dihydroxybutanoic acid and 2,4-dihydroxybutanoic acid were selected as common differential metabolites in both cohorts. Pathway analysis revealed that the pentose and glucuronate interconversions pathway was significantly affected in native CKD patients, whereas phenylalanine, tyrosine, and tryptophan biosynthesis pathway and tyrosine metabolism pathway were the most affected pathways in KTRs. Further comparisons between native CKD and KTRs who were at the same kidney dysfunction stages demonstrated that KTRs showed significantly higher levels of malic acid, but lower levels of D-allose compared to native CKD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study not only identified the 6 metabolites associated with kidney function in both non-transplant patients and KTRs, but also determined 5 and 7 metabolites that were specifically associated with kidney dysfunction in native CKD patients and KTRs, respectively. These data suggest that the metabolic process may be influenced by the unique characteristics of kidney transplantation, such as allogeneic immunity and immunosuppressive drugs, in KTRs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05000-1","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:47:06Z","timestamp":1777481226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum metabolites in relation to kidney function in non-transplant and kidney transplant settings using gas chromatography-mass spectrometry"],"prefix":"10.1186","volume":"27","author":[{"given":"Yamei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"5000_CR1","doi-asserted-by":"crossref","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1).","DOI":"10.1016\/j.kisu.2021.11.003"},{"issue":"8","key":"5000_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJMra2014530","volume":"385","author":"S Hariharan","year":"2021","unstructured":"Hariharan S, Israni AK, Danovitch G. Long-Term Survival after Kidney Transplantation. N Engl J Med. 2021;385(8):729\u201343.","journal-title":"N Engl J Med"},{"issue":"6","key":"5000_CR3","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089\u2013100.","journal-title":"Kidney Int"},{"key":"5000_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","volume":"81","author":"WR Zhang","year":"2019","unstructured":"Zhang WR, Parikh CR. Biomarkers of Acute and Chronic Kidney Disease. Annu Rev Physiol. 2019;81:309\u201333.","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"5000_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2215\/CJN.09310819","volume":"15","author":"E Cohen","year":"2020","unstructured":"Cohen E, Korah M, Callender G, Belfort de Aguiar R, Haakinson D. Metabolic Disorders with Kidney Transplant. Clin J Am Soc Nephrol. 2020;15(5):732\u201342.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5000_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1743-7075-9-36","volume":"9","author":"AD Slee","year":"2012","unstructured":"Slee AD. Exploring metabolic dysfunction in chronic kidney disease. Nutr Metabolism. 2012;9(1):36.","journal-title":"Nutr Metabolism"},{"issue":"5","key":"5000_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ackd.2016.09.006","volume":"23","author":"S Parajuli","year":"2016","unstructured":"Parajuli S, Clark DF, Djamali A. Is Kidney Transplantation a Better State of CKD? Impact on Diagnosis and Management. Adv Chronic Kidney Dis. 2016;23(5):287\u201394.","journal-title":"Adv Chronic Kidney Dis"},{"key":"5000_CR8","doi-asserted-by":"publisher","first-page":"113765","DOI":"10.1016\/j.fct.2023.113765","volume":"176","author":"X Dai","year":"2023","unstructured":"Dai X, Liu M, Xu S, Zhao H, Li X, Bai Y, Zou Y, An Y, Fan F, Zhang J, et al. Metabolomics profile of plasma in acute diquat-poisoned patients using gas chromatography-mass spectrometry. Food Chem Toxicol. 2023;176:113765.","journal-title":"Food Chem Toxicol"},{"issue":"W1","key":"5000_CR9","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques PE, Li S, Xia J. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388\u201396.","journal-title":"Nucleic Acids Res"},{"key":"5000_CR10","doi-asserted-by":"publisher","first-page":"1119782","DOI":"10.3389\/fendo.2023.1119782","volume":"14","author":"Y Tan","year":"2023","unstructured":"Tan Y, Liu X, Yang Y, Li B, Yu F, Zhao W, Fu C, Yu X, Han Z, Cheng M. Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia. Front Endocrinol (Lausanne). 2023;14:1119782.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5000_CR11","doi-asserted-by":"publisher","first-page":"986303","DOI":"10.3389\/fendo.2022.986303","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Tang J, Jin E, Ren C, Li S, Zhang L, Zhong Y, Cao Y, Wang J, Zhou W, et al. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes. Front Endocrinol (Lausanne). 2022;13:986303.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"21","key":"5000_CR12","doi-asserted-by":"publisher","first-page":"e2300218","DOI":"10.1002\/mnfr.202300218","volume":"67","author":"Y Hui","year":"2023","unstructured":"Hui Y, Zhao J, Yu Z, Wang Y, Qin Y, Zhang Y, Xing Y, Han M, Wang A, Guo S, et al. The Role of Tryptophan Metabolism in the Occurrence and Progression of Acute and Chronic Kidney Diseases. Mol Nutr Food Res. 2023;67(21):e2300218.","journal-title":"Mol Nutr Food Res"},{"issue":"12","key":"5000_CR13","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2337\/dc23-1147","volume":"46","author":"J-J Liu","year":"2023","unstructured":"Liu J-J, Ching J, Wee HN, Liu S, Gurung RL, Lee J, M Y, Zheng H, Lee LS, Ang K, et al. Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes. Diabetes Care. 2023;46(12):2223\u201331.","journal-title":"Diabetes Care"},{"key":"5000_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3389\/fendo.2019.00818","volume":"10","author":"N Tofte","year":"2019","unstructured":"Tofte N, Suvitaival T, Trost K, Mattila IM, Theilade S, Winther SA, Ahluwalia TS, Frimodt-M\u00f8ller M, Legido-Quigley C, Rossing P. Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes. Front Endocrinol. 2019;10:818.","journal-title":"Front Endocrinol"},{"issue":"8","key":"5000_CR15","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, Chu Q, Yuan X, Bao Z, Lu J, et al. Tryptophan metabolism in health and disease. Cell Metabol. 2023;35(8):1304\u201326.","journal-title":"Cell Metabol"},{"issue":"5","key":"5000_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI31178","volume":"117","author":"DH Munn","year":"2007","unstructured":"Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest. 2007;117(5):1147\u201354.","journal-title":"J Clin Invest"},{"key":"5000_CR17","doi-asserted-by":"crossref","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023;12(12).","DOI":"10.3390\/cells12121581"},{"issue":"2","key":"5000_CR18","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/jcsm.13193","volume":"14","author":"T Xie","year":"2023","unstructured":"Xie T, Lv T, Zhang T, Feng D, Zhu F, Xu Y, Zhang L, Gu L, Guo Z, Ding C, et al. Interleukin-6 promotes skeletal muscle catabolism by activating tryptophan-indoleamine 2,3-dioxygenase 1-kynurenine pathway during intra-abdominal sepsis. J Cachexia Sarcopenia Muscle. 2023;14(2):1046\u201359.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Suppl 10","key":"5000_CR19","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2164-15-S10-S4","volume":"15","author":"A Vandenbon","year":"2014","unstructured":"Vandenbon A, Teraguchi S, Takeuchi O, Suzuki Y, Standley DM. Dynamics of enhancers in myeloid antigen presenting cells upon LPS stimulation. BMC Genomics. 2014;15(Suppl 10):S4.","journal-title":"BMC Genomics"},{"issue":"7","key":"5000_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2741\/4363","volume":"20","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu D, Song P, Zou M-H. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Front Biosci (Landmark Ed). 2015;20(7):1116\u201343.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"8","key":"5000_CR21","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/ndt\/gft217","volume":"28","author":"ON Goek","year":"2013","unstructured":"Goek ON, Prehn C, Sekula P, Romisch-Margl W, Doring A, Gieger C, Heier M, Koenig W, Wang-Sattler R, Illig T, et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol Dial Transpl. 2013;28(8):2131\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"5000_CR22","doi-asserted-by":"publisher","first-page":"102445","DOI":"10.1016\/j.jbc.2022.102445","volume":"298","author":"K Duangkumpha","year":"2022","unstructured":"Duangkumpha K, Jariyasopit N, Wanichthanarak K, Dhakal E, Wisanpitayakorn P, Thotsiri S, Sirivatanauksorn Y, Kitiyakara C, Sathirapongsasuti N, Khoomrung S. GC x GC-TOFMS metabolomics analysis identifies elevated levels of plasma sugars and sugar alcohols in diabetic mellitus patients with kidney failure. J Biol Chem. 2022;298(10):102445.","journal-title":"J Biol Chem"},{"issue":"11","key":"5000_CR23","first-page":"1285","volume":"12","author":"SJ Han","year":"2005","unstructured":"Han SJ, Jeong SY, Nam YJ, Yang KH, Lim HS, Chung J. Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis. Clin Diagn Lab Immunol. 2005;12(11):1285\u201391.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"5000_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/ijo.2013.1917","volume":"43","author":"EY Yi","year":"2013","unstructured":"Yi EY, Kim YJ. Xylitol inhibits in vitro and in vivo angiogenesis by suppressing the NF-kappaB and Akt signaling pathways. Int J Oncol. 2013;43(1):315\u201320.","journal-title":"Int J Oncol"},{"issue":"9","key":"5000_CR25","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00467-015-3135-1","volume":"30","author":"K Vanlede","year":"2015","unstructured":"Vanlede K, Kluijtmans LAJ, Monnens L, Levtchenko E. Urinary excretion of polyols and sugars in children with chronic kidney disease. Pediatr Nephrol. 2015;30(9):1537\u201340.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"5000_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0026-0495(70)90114-9","volume":"19","author":"IM Spitz","year":"1970","unstructured":"Spitz IM, Rubenstein AH, Bersohn I, B\u00e4ssler KH. Metabolism of xylitol in healthy subjects and patients with renal disease. Metabolism. 1970;19(1):24\u201334.","journal-title":"Metabolism"},{"issue":"3","key":"5000_CR27","doi-asserted-by":"publisher","first-page":"e13770","DOI":"10.1111\/cts.13770","volume":"17","author":"Z Tan","year":"2024","unstructured":"Tan Z, Wang Z, Zeng Q, Liu X, Zhang Y, Li S, Huang J, Zeng Y, Huang Z, Jin C, et al. Natural intestinal metabolite xylitol reduces BRD4 levels to mitigate renal fibrosis. Clin Transl Sci. 2024;17(3):e13770.","journal-title":"Clin Transl Sci"},{"issue":"21","key":"5000_CR28","doi-asserted-by":"publisher","first-page":"E4233","DOI":"10.1073\/pnas.1620079114","volume":"114","author":"KC Hootman","year":"2017","unstructured":"Hootman KC, Trezzi JP, Kraemer L, Burwell LS, Dong X, Guertin KA, Jaeger C, Stover PJ, Hiller K, Cassano PA. Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults. Proc Natl Acad Sci U S A. 2017;114(21):E4233\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2 Pt 2","key":"5000_CR29","doi-asserted-by":"publisher","first-page":"S280","DOI":"10.1006\/rtph.1996.0109","volume":"24","author":"FR Bornet","year":"1996","unstructured":"Bornet FR, Blayo A, Dauchy F, Slama G. Plasma and urine kinetics of erythritol after oral ingestion by healthy humans. Regul Toxicol Pharmacol. 1996;24(2 Pt 2):S280\u20135.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"5000_CR30","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1038\/s41598-018-32085-y","volume":"8","author":"JK Haukka","year":"2018","unstructured":"Haukka JK, Sandholm N, Forsblom C, Cobb JE, Groop PH, Ferrannini E. Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes. Sci Rep. 2018;8(1):13853.","journal-title":"Sci Rep"},{"key":"5000_CR31","doi-asserted-by":"publisher","first-page":"1045843","DOI":"10.3389\/fphar.2022.1045843","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu H, Wang M, Xiong X, Du Y, Li D, Wang Z, Ge W, Zhu Y. Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients. Front Pharmacol. 2022;13:1045843.","journal-title":"Front Pharmacol"},{"key":"5000_CR32","doi-asserted-by":"crossref","unstructured":"Joncquel M, Labasque J, Demaret J, Bout MA, Hamroun A, Hennart B, Tronchon M, Defevre M, Kim I, Kerckhove A, et al. Targeted metabolomics analysis suggests that tacrolimus alters protection against oxidative stress. Antioxid (Basel). 2023;12(7).","DOI":"10.3390\/antiox12071412"},{"key":"5000_CR33","doi-asserted-by":"crossref","unstructured":"Bellorin-Font E, Rojas E, Martin KJ. Bone disease in chronic kidney disease and kidney transplant. Nutrients. 2022;15(1).","DOI":"10.3390\/nu15010167"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05000-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:35:31Z","timestamp":1781742931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5000"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05000-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of the West China Hospital of Sichuan University (no. 2017\u2009\u2212\u2009397). All participants provided written informed consent prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}